SIV vaccines, 1991--a year in review.
Gardner
M B
MB
Department of Pathology, School of Medicine, University of California, Davis.
Hu
S L
SL
D016915:AIDS Vaccines / Q000627:therapeutic use; D000818:Animals; D002472:Cell Transformation, Viral; D008251:Macaca; D011994:Recombinant Proteins / Q000276:immunology; D016097:Simian Acquired Immunodeficiency Syndrome / Q000517:prevention & control* / Q000628:therapy; D015302:Simian Immunodeficiency Virus / Q000276:immunology*; D013601:T-Lymphocytes / Q000276:immunology; D014613:Vaccines, Attenuated; D015164:Vaccines, Inactivated; D014614:Vaccines, Synthetic; D014759:Viral Envelope Proteins / Q000276:immunology; D014765:Viral Vaccines / Q000627:therapeutic use
D016915:AIDS Vaccines; D011994:Recombinant Proteins; D014613:Vaccines, Attenuated; D015164:Vaccines, Inactivated; D014614:Vaccines, Synthetic; D014759:Viral Envelope Proteins; D014765:Viral Vaccines